Javascript must be enabled to continue!
Hemophilia
View through CrossRef
Hemophilia is a family of rare bleeding disorders characterized by deficiency of clotting factors. Hemophilia A is an inherited deficiency of factor VIII, whereas hemophilia B (Christmas disease) represents a deficiency of factor IX. Both hemophilia A and B are X-linked diseases, with hemophilia A accounting for 80 to 85% of cases and hemophilia B 15 to 20%. Although hemophilia has historically referred to deficiencies of factors VIII and IX, it is important to recognize that similar bleeding disorders can occur with other missing clotting factors, although this is far more rare. This review covers the definition, history, epidemiology, biology/genetics, clinical manifestations, diagnosis, differential diagnosis, treatment, complications, measures of quality of care, and prognosis of hemophilia, as well as future directions. Figures show the clotting cascade, the genetic makeup of severe hemophilia A, an algorithm for diagnosing hemophilia, and hemophilic arthropathy in a patient’s knees. Tables list severity in hemophilia A and B, treatment of acute bleeding in hemophilia A and B, frequency of dosing in acute bleeding, and treatment of acute bleeding with inhibitors.
This review contains 4 highly rendered figures, 4 tables, and 59 references.
Title: Hemophilia
Description:
Hemophilia is a family of rare bleeding disorders characterized by deficiency of clotting factors.
Hemophilia A is an inherited deficiency of factor VIII, whereas hemophilia B (Christmas disease) represents a deficiency of factor IX.
Both hemophilia A and B are X-linked diseases, with hemophilia A accounting for 80 to 85% of cases and hemophilia B 15 to 20%.
Although hemophilia has historically referred to deficiencies of factors VIII and IX, it is important to recognize that similar bleeding disorders can occur with other missing clotting factors, although this is far more rare.
This review covers the definition, history, epidemiology, biology/genetics, clinical manifestations, diagnosis, differential diagnosis, treatment, complications, measures of quality of care, and prognosis of hemophilia, as well as future directions.
Figures show the clotting cascade, the genetic makeup of severe hemophilia A, an algorithm for diagnosing hemophilia, and hemophilic arthropathy in a patient’s knees.
Tables list severity in hemophilia A and B, treatment of acute bleeding in hemophilia A and B, frequency of dosing in acute bleeding, and treatment of acute bleeding with inhibitors.
This review contains 4 highly rendered figures, 4 tables, and 59 references.
Related Results
Antithrombotic Therapy in People with Hemophilia—A Narrative Review
Antithrombotic Therapy in People with Hemophilia—A Narrative Review
As the life expectancy of individuals with hemophilia continues to increase, the complexity of balancing bleeding risks and thrombotic management has become increasingly critical i...
A Systematic Review of the Oral Health Status of Hemophilic Patients
A Systematic Review of the Oral Health Status of Hemophilic Patients
Background: Hemophilia is an inherited bleeding disorder, with the most well-known forms being hemophilia A and hemophilia B. It is important for patients with hemophilia to mainta...
Pre- and Perinatal Relations of Hemophilia A and B
Pre- and Perinatal Relations of Hemophilia A and B
<i>Objective:</i> The authors conducted a retrospective study of obstetric and genetic data, obstetric problems, and pregnancy outcome by investigating 149 pregnancies ...
CRISPR/Cas9-mediated knockin of human factor IX into swine factor IX locus effectively alleviates bleeding in hemophilia B pigs
CRISPR/Cas9-mediated knockin of human factor IX into swine factor IX locus effectively alleviates bleeding in hemophilia B pigs
Hemophilia B is an X-linked recessive bleeding disorder caused by abnormalities in the coagulation factor IX gene. Without prophylactic treatment, patients experience frequent spon...
Health-Related Quality of Life Assessment in Iranian Hemophilia Patients (Single Center); A Cross-Sectional Study
Health-Related Quality of Life Assessment in Iranian Hemophilia Patients (Single Center); A Cross-Sectional Study
Abstract
Background: Hemophilia affects the patients′ life in many aspects. The major concerns are restriction on physical activities, life-threatening bleeding, arthropath...
An RNAi Therapeutic Targeting Antithrombin Increases Thrombin Generation in Nonhuman Primates
An RNAi Therapeutic Targeting Antithrombin Increases Thrombin Generation in Nonhuman Primates
Abstract
Abstract 3370
The hemostatic system balances the need to control blood loss with the need to prevent thrombosis. In hemophilia, the loss of c...
Frequency of Inhibitors among known Hemophilia A Patients.
Frequency of Inhibitors among known Hemophilia A Patients.
ABSTRACT
Introduction: Inhibitors are IgG alloantibodies which are directed against exogenous clotting factor VIII that neutralize the function of infused clotting factor con...
Haemophilia Care in Martinique: From 1982 to 2015
Haemophilia Care in Martinique: From 1982 to 2015
Abstract
Introduction: Hemophilia A (HA) and B (HB) are the most common congenital bleeding disorders, characterised by missing clotting factor VIII (FVIII) for HA o...

